How peptide safety and purity are actually assessed - the Certificate of Analysis, contamination, HPLC and mass-spec, and why evidence beats marketing.
12 articles tagged “Safety & Quality”
A research-first breakdown of the body protection compound - what BPC-157 is, the preclinical-only evidence base, the peptide-vs-steroid question, why recovery and hormonal claims overreach, and why purity and COAs matter.
The label is the claim; the COA is the evidence. Mass spectrometry for identity, HPLC for purity, batch numbers for traceability - what a strong COA includes and the red flags that signal marketing over testing.
How TB-500 relates to (but differs from) Thymosin Beta-4, what the preclinical tissue-repair and cell-migration literature actually studies, the human-trial gap, and why it is prohibited in tested sport.
Not in the way the word suggests. BPC-157 is a research-use-only compound; the FDA's 2023 review kept it off the 503A Bulks List for human-use compounding, it returns for discussion in July 2026, and WADA prohibits it in sport. The nuance behind "banned", explained.
FDA-approved injectable medicines vs unapproved research compounds, what the 2026 press wave (Guardian, AP, MIT Tech Review, AMA) actually reported, and whether peptide injections are safe. Research use only; not for human use; not medical advice.
How to spot the best peptide company for research: the per-batch third-party Certificate of Analysis, HPLC and mass-spec testing, reference standards, the grey-market red flags, and a copy-paste vetting checklist. Research use only.
GMP and pharmacopoeia standards vs research-use-only purity, why “pharma grade” is often a marketing term on research products, and how to verify what is really in the vial with a per-batch CoA. Research use only.
What bacteriostatic water is, bacteriostatic vs sterile water, exactly how much to add (the concentration = mass ÷ volume math), shelf life and storage, and the reconstitution technique. The standard solvent for research-peptide reconstitution. Research use only.
The 15-amino-acid pentadecapeptide derived from a body protective compound first isolated in human gastric juice. Mechanism (angiogenesis, NO modulation, fibroblast migration), the pre-clinical evidence base, the human-trial gap, and the “Wolverine stack” framing with TB-500.
Sourcing, purity and compliance for research peptides like BPC-157, GHK-Cu and TB-500: vetting suppliers, the per-batch Certificate of Analysis, >99% HPLC, the US/UK research-use-only framing and lab handling. Research use only.
“Safe” is not a property of peptides as a category. How safety is really assessed - purity, contamination, the Certificate of Analysis, and why “research use only” is a statement about evidence.
HPLC, mass spec, endotoxins - what those lines on a peptide COA actually tell you when comparing suppliers for research.
Research use only. These articles summarise public literature and catalogue facts. They do not diagnose, treat, or prevent any disease, and are not medical advice.